BiotechTube
Home/Mesenkia Therapeutics/Liselotte Larsson
LL

Liselotte Larsson

CMC Expert

Mesenkia Therapeutics

Therapeutic Areas

OncologyNeuro-oncology

Mesenkia Therapeutics Pipeline

DrugIndicationPhase
HV01GlioblastomaPre-clinical

Leadership Team at Mesenkia Therapeutics

MF
Moa Fransson
CEO
KM
Kohei Miyazono
Scientific Founder
CH
Carl-Henrik Heldin
Scientific Founder
BW
Bengt Westermark
Scientific Founder
CD
Cecilia Drakskog
Project Manager
View full Mesenkia Therapeutics profile